Blog Posts

BIG PHARMA EARNINGS WATCH: ELI LILLY & NOVO NORDISK

Aug 21, 2026

Big Pharma Giants Smash Second Quarter Earnings After Price Hikes Across Their Read More

BIG PHARMA EARNINGS WATCH: AMGEN, MERCK, GILEAD & PFIZER

Aug 10, 2026

Pharmaceutical Giants Beat Earnings Estimates Following Price Hikes to Start Read More

BIG PHARMA EARNINGS WATCH: SANOFI, BRISTOL MYERS SQUIBB & ABBVIE

Aug 4, 2026

Brand Name Drug Companies Tout Patent Strategies on Blockbusters That Block Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA & GSK

Jul 29, 2026

Brand Name Drug Companies Book Blockbuster Profits Following Price Hikes Read More

CSRxP ANALYSIS: BIG PHARMA’S PROFIT MARGINS CLIMB TO 11 TIMES GREATER THAN OTHER SECTORS IN DRUG SUPPLY CHAIN

Jul 27, 2026

Brand Name Drug Companies Banking Ever Higher Profits Fueled by Egregious Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS & ROCHE

Jul 27, 2026

Big Pharma Giants Continue Topping Wall Street Expectations Following Price Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jul 17, 2026

Johnson & Johnson Tops Profit Expectations, Lifts Outlook Following Price Read More

DOSE OF REALITY: REPORT FINDS BIG PHARMA CONTINUES TO SET OUT-OF-CONTROL LAUNCH PRICES ON NEW MEDICINES COMING TO MARKET

Jul 2, 2026

Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025 Read More

SECOND OPINION: CLOSING LOOPHOLES BIG PHARMA EXPLOITS TO BLOCK COMPETITION AND KEEP DRUG PRICES HIGH WILL NOT UNDERMINE INNOVATION

Jun 16, 2026

Big Pharma’s Arguments Against Bipartisan, Market-Based Solutions to Foster Read More

THEY SAID IT! LAWMAKERS AND EXPERTS SUPPORT BIPARTISAN, MARKET-BASED SOLUTIONS TO LOWER DRUG PRICES, FOSTER GREATER COMPETITION

Jun 5, 2026

U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC Read More

THEY SAID IT! BROAD BASED SUPPORT FOR BIPARTISAN ETHIC ACT AND SKINNY LABELS, BIG SAVINGS ACT

Jun 2, 2026

Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based Read More